deoxyuridine has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, P; Liang, QL; Luo, GA; Wang, YM; Xia, JF; Zou, TT | 1 |
| Bénardeau, A; Bosco, D; Brecheisen, M; Migliorini, C; Prummer, M; Sebokova, E; Sewing, S; Tobalina, L; Uhles, S; Wang, H; Wollheim, CB | 1 |
2 other study(ies) available for deoxyuridine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Correlations of creatine and six related pyrimidine metabolites and diabetic nephropathy in Chinese type 2 diabetic patients.
Topics: Aged; Chromatography, High Pressure Liquid; Creatine; Cytidine; Cytosine; Deoxyuridine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Pyrimidines; Tandem Mass Spectrometry; Thymidine; Thymine; Uridine | 2010 |
Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo.
Topics: Animals; Apoptosis; Cells, Cultured; Deoxyuridine; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Immunohistochemistry; Insulin-Secreting Cells; Male; Peptides; Rats; Rats, Zucker; Receptors, Glucagon | 2011 |